Abbott India Ltd.
| BSE: 500488 | Sector: Health care |
| NSE: ABBOTINDIA | ISIN Code: INE358A01014 |
| BSE 00:00 | 24 Apr | Abbott India Ltd is not traded on BSE in the last 30 days |
| NSE 05:30 | 01 Jan | Abbott India Ltd is not traded on NSE in the last 30 days |
| OPEN | 16400.00 |
| PREVIOUS CLOSE | 16395.60 |
| VOLUME | 387 |
| 52-Week high | 18500.00 |
| 52-Week low | 7150.00 |
| P/E | 58.69 |
| Mkt Cap.(Rs cr) | 34,932 |
| Buy Price | 16438.55 |
| Buy Qty | 1.00 |
| Sell Price | 16530.00 |
| Sell Qty | 25.00 |
About Abbott India Ltd.
Abbott India Ltd
Abbott India Ltd is one of the largest MNC pharma companies operating in India. It is a subsidiary of Abbott Laboratories of USA. Abbott Laboratories held 75% stake in Abbott India as on 31 March 2018. The company is engaged in the discovery development manufacture and marketing of pharmaceutical diagnostic nutritional and hospital products. They are having their presence in both OTC drugs and for...> More
Abbott India Ltd - Key Fundamentals
| Parameter | Values | ||
| Market Cap | ( cr)
|
34,932 | |
| EPS - TTM | () |
[*S] | 280.07 |
| P/E Ratio | (X) | [*S] | 58.69 |
| Face Value | () |
10 | |
| Latest Dividend | (%) | 500.00 | |
| Latest Dividend Date | 13 Aug 2019 | ||
| Dividend Yield | (%) | 0.40 | |
| Book Value / Share | () |
[*S] | 1003.46 |
| P/B Ratio | () |
[*S] | 16.38 |
Abbott India Ltd - Financial Results
Particulars ( cr) |
Dec 2019 | Dec 2018 | % Chg |
| Net Sales | 1078.25 | 947.65 | 13.78 |
| Other Income | 27.76 | 37.63 | -26.23 |
| Total Income | 1106.01 | 985.28 | 12.25 |
| Total Expenses | 838.55 | 801.16 | 4.67 |
| Operating Profit | 267.46 | 184.12 | 45.26 |
| Net Profit | 186.69 | 117.05 | 59.5 |
| Equity Capital | 21.25 | 21.25 | - |
Abbott India Ltd - Peer Group
| Company | Price() |
Chg (%) | Mkt Cap ( CR) |
| Torrent Pharma. | 2431.60 | 0.43 | 41147.54 |
| Lupin | 877.25 | 6.73 | 39743.81 |
| Aurobindo Pharma | 623.95 | -0.79 | 36557.23 |
| Abbott India | 16438.55 | 0.26 | 34931.92 |
| Cadila Health. | 336.95 | 1.57 | 34493.57 |
| Alkem Lab | 2737.25 | 8.61 | 32723.82 |
| Glaxosmi. Pharma | 1454.45 | 0.50 | 24639.84 |
Abbott India Ltd - SHAREHOLDING PATTERN
|
|
|
Promoters
Banks/FIs
FIIs
Insurance
Mutual Funds
Indian Public
Custodians
OtherAbbott India Ltd - RETURNS
| Period | BSE | NSE | Sensex | NIFTY |
| 1 Week | -3.13% | -2.83% | -0.83% | -1.21% |
| 1 Month | 18.75% | 18.77% | 17.44% | 17.35% |
| 3 Month | 30.45% | 30.50% | -24.72% | -25.26% |
| 6 Month | 47.32% | 47.95% | -19.72% | -20.96% |
| 1 Year | 109.86% | 110.08% | -19.79% | -21.93% |
| 3 Year | 267.72% | 268.38% | 5.64% | -0.69% |
Abbott India Ltd - STOCK STRENGTH
| Today's Low/High | 16238.70 |
|
16597.00 |
| Week Low/High | 16238.70 |
|
17675.00 |
| Month Low/High | 13200.00 |
|
18500.00 |
| YEAR Low/High | 7150.00 |
|
18500.00 |
| All TIME Low/High | 31.50 |
|
18500.00 |
Quick Links for Abbott India:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
